Last reviewed · How we verify
NCT07165392
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Upper Limb: a Double-blind Randomized Clinical Trial
NA trial testing Neuromodulation in Neuromodulation in 120 participants. Not yet recruiting.
1 November 2025
Quick facts
| Lead sponsor | University of Malaga |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 October 2025 |
| Primary completion | 1 November 2025 |
| Estimated completion | 31 March 2027 |
Drugs / interventions tested
- Neuromodulation
- Physical Exercise
- Stretching
Conditions studied
- Neuromodulation — all drugs for Neuromodulation →
- Upper Limb — all drugs for Upper Limb →
- Musculoskeletal Disorders — all drugs for Musculoskeletal Disorders →
Sponsor
University of Malaga
Who can join
Adults 18 to 60, any sex, with Neuromodulation or Upper Limb. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to analyze the use of neuromodulation within a treatment protocol for musculoskeletal conditions of the upper limb, as well as to determine the difference between two and three sessions per week. Study participants will be divided into four intervention groups: the first will receive two sessions per week for a period of six months, while the second will receive three sessions per week for the same period. The treatment protocol will consist of therapeutic physical exercise focused on the muscles and joints of the lower limb, stretching of the involved muscles, and neuromodulation of the brachial plexus nerve root, which innervates the affected structures. The third and fourth intervention groups will receive the same treatment as mentioned above, but without neuromodulation. The third group will receive three sessions per week, while the second group will receive two sessions per week. Two different types of measurement variables will be used: objective variables will be used to measure range of motion and muscle strength. Subjective variables will also be used through validated questionnaires, covering physical activity, health-related quality of life, upper limb function, and a visual analog scale for pain perception.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07165392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neuromodulation
Trials testing the same drug.
- NCT07266662 — Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors · NA · recruiting
- NCT07165379 — Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Muscul · NA · not yet recruiting
- NCT06783374 — Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence · NA · recruiting
- NCT06193278 — Individual Neuromodulation for PDS · NA · unknown
- NCT06790563 — Neuromodulation of the Dorsal Genital Nerve in Persistent Genital Arousal Disorder · NA · completed
Other recruiting trials for Neuromodulation
Currently open trials in the same condition.
- NCT06996574 — Study to Compare the Clinical Effectiveness and Cost Utility of an All-in-one Procedure With an At-home Screening Trial · NA · recruiting
- NCT07155733 — tVNS and Myofascial Release in Tinnitus · NA · active not recruiting
- NCT07467642 — A Neuromodulation Auditory System to Optimize Patient Experience During Dysfunctional Dialysis Access Endovascular Proce · NA · active not recruiting
- NCT06515223 — Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury · NA · recruiting
- NCT06464445 — Optimization of ITBS for Depression · NA · recruiting
Other University of Malaga trials
Trials by the same sponsor.
- NCT07472205 — Foot and Ankle Strengthening Program to Improve Physical Function in Menopausal Women · NA · not yet recruiting
- NCT07408622 — Virtual Reality Therapy for Wrist and Hand Injury Recovery · NA · not yet recruiting
- NCT07428304 — Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography · not yet recruiting
- NCT07371715 — Home-Based Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) for Sleep Quality and Psycho-Academic Outcomes in Hea · NA · not yet recruiting
- NCT06438666 — Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children Wit · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07165392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Malaga
- Last refreshed: 10 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07165392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing